Maynard Um
-
-
-
-
-
-
-
Galectin presents NAVIGATE trial biomarker data at liver meeting
-
-
-
-
-
-
-
Galectin Therapeutics (GALT) Reports Significant Reduction in New Varices with Belapectin in U.S. Patient Population from the NAVIGATE Trial
-
-
-
-
-
-
-
Increasing unusual put option volume: GALT NWL ACHR IAU QBTS CIEN VTRS BAH
-
-
445,968 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

